Haisco Pharmaceutical Group
¥62.18Change from previous close: +0.40%Absolute change: +¥0.25
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ¥70.94B
- Enterprise value
- ¥70.58B
- P/E (trailing 12 months)
- 73.2
- Forward P/E
- 45.0
- Price/book
- 14.6
- Price/sales
- 12.9
- EV/EBITDA
- 62.7
- EV/revenue
- 12.9
Profitability and growth
- Gross margin
- 75.6%
- Operating margin
- 16.9%
- Net margin
- 17.3%
- ROE
- 21.4%
- ROA
- 7.0%
- Revenue growth (year over year)
- 38.1%
- Earnings growth (year over year)
- 145.4%
Financial health
- Total cash
- ¥1.98B
- Total debt
- ¥2.26B
- Debt/equity
- 0.47
- Current ratio
- 1.53
- Quick ratio
- 1.35
Dividends
- Annual dividend per share
- ¥0.79
- Dividend yield
- 1.3%
- Payout ratio
- 31.6%
- Ex-dividend date
- September 4, 2026
Analysts and estimates
- Average price target
- ¥88.45
- Median price target
- ¥88.45
- High price target
- ¥96.89
- Low price target
- ¥80.00
- Analysts with a price target
- 2
- Forward EPS
- ¥1.38
- EPS estimate, current year
- ¥1.44
Shares and trading
- Beta
- -0.21
- Average volume
- 9.15M
- Shares outstanding
- 1.14B
- Float
- 266.08M
- Institutional ownership
- 11.8%
- Insider ownership
- 74.4%